Take Home Message A combined prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT)–magnetic resonance imaging (MRI) model improved extraprostatic extension prediction in development but showed similar performance to MRI in external validation. The added value of PSMA PET/CT a...
V. Sweere, A. B. Bruins Slot, J. Heetman et al.· European Urology Open Scienc...· 0 citations
ABSTRACT Activation of the RAS/RAF/ERK pathway is crucial for adaptive immunity. Here, we provide evidence that Sprouty‐related EVH1 domain containing 2 (SPRED2), an endogenous inhibitor of this pathway, negatively regulates CD8+ T cell‐mediated antitumor immunity in breast cancer. In EO771 and 4T1 mouse models, Spred2...
M. Tian, Teizo Yoshimura, Kun Zhao et al.· Advancement of science· 0 citations
Perioperative immunotherapy has become the standard of care in patients with high‐risk muscle‐invasive urothelial carcinoma (MIUC). This study aimed to clarify oncological outcomes and safety profiles of adjuvant nivolumab therapy in MIUC, focusing on upper tract urothelial carcinoma (UTUC).
Satoshi Katayama, Tatsushi Kawada, K. Mori et al.· International journal of uro...· 1 citation
We aimed to stratify clinical risk among patients with high‐volume metastatic hormone‐sensitive prostate cancer (mHSPC) treated with first‐line androgen receptor pathway inhibitor (ARPI) plus androgen deprivation therapy (ADT).
Keiichiro Miyajima, T. Yanagisawa, Wataru Fukuokaya et al.· International journal of uro...· 0 citations
It is demonstrated that histological section thickness is not merely a microtome setting but a variable, tissue-dependent, and AI-inferable physical property of routine H&E sections that represents an underrecognized preanalytical source of image variation and a potential target for AI-assisted, thickness-aware quality...
GG at the PSM independently predicts BCR, with the strongest effect in lower-grade tumors (ISUP 1-2; HR 7.08 for GG4), attenuated in high-grade disease (HR 2.98).
Mehdi Kardoust Parizi, A. Matsukawa, Ichiro Tsuboi et al.· Clinical Genitourinary Cance...· 0 citations
To evaluate perioperative safety, pathological outcomes, and oncological outcomes of en bloc resection of bladder tumor (ERBT) in a large multicenter real‐world cohort.
T. Yanagisawa, A. Matsukawa, K. Iwatani et al.· International journal of uro...· 0 citations
Available evidence does not support a strong or consistent association between dietary factors and bladder cancer (BC) risk, and patients should be informed that dietary modifications alone are unlikely to meaningfully alter their BC risk.
Keiichiro Miyajima, Marcin Miszczyk, Navid Roessler et al.· BJU International· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.